Hodgkin’s Disease in HIV patients: Two clinical case reports
Keywords:
fever, Hodgkin disease, HIV infectionAbstract
The authors describe two clinical cases of prolonged fever in HIV
positive patient. The diagnostic study revealed Hodgkin’s disease
in both cases.
Downloads
References
Gérard L, Galicier L, Boulanger E et al. Improved survival in HIV-related Hodgkin lymphoma since the introduction of highly active antiretroviral therapy, AIDS 2003:17: 81-87.
Tirelli U, Errante D, Dolcetti R et al. Hodgkin disease and human imunodeficiency virus infection: clinicopathologic and virulogic features of 114 patients from Italian cooperative group on AIDS and tumors, Journal of clinical oncology 1995;13: 1758-1767.
Serraino D, Boschini A, Carrieri P et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe, AIDS 2000; 14 (5): 553-559.
Powles T, Bower M. HIV-associated Hodgkin disease, Int J STD AIDS 2000; 11(8); 492-494.
Spina M, Vaccher E, Nasti G, Tirelli U. Human immunodeficiency virus-associated Hodgkin`s disease, Semin Oncol 2000; 27 (4):480-488.
Grulich A, Wan X, Law M, Coates M, Kaldor M. Risk of cancer in people with AIDS, AIDS 1999;13:839-843.
Levine AM. Clinical aspects of AIDS- Related Lymphoma and Hodgkin Disease, 6th International Conference of Malignancies in AIDS & other Immunodeficiencies 2001.
Ribera JM, Navarro JT, Oriol A et al. Prognostic impact of active antiretroviral therapy in HIV-related Hodgkin´s disease, AIDS 2002;16 (14) 1973-1975.
Kaplan LD. Clinical Presentation and Management of HIV- Associated Lymphoma, HIV inSite Knowledge Base Chapter Published November, 1998.
Levine A, Li P, Cheung T et al. Chemotherapy consisting of Doxurobicin, Bleomicin, Vimblastin, and Dacarbazin with Granulocyte-Colony-Stimulating Factor in HIV-infected patients with newly diagnosed Hodgkin Disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149), JAIDS 2000; 24:444-450.
Navarro JT, Ribera JM, Grau J et al. Hodgkin disease in patients infected by human immunodeficiency virus. Study of fifteen cases, Med clin (Barc) 2000; 114 (1); 19-21.
Little RF, Yarchoan R, Wilson WH. Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy, Curr Opin Oncol 2000; 12 (5); 438-444.
Errante D, Gabarre G, Ridolfo AL et al. Hodgkin disease in 35 patients with HIV infection: na experience with epirubicin, bleomicin, vimblastin and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF, Ann Oncol 1999; 10(2):189-195.
Dennis A. Casciato, Barry B. Lowitz, Manual of clinical oncology, 2000 Lippincott Williams and Wilkins fourth edition 2000; 402; 682-685.
Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A. Epidemiologiocal, biological and clinical features of HIV-related lynphomas in the era of high active antiretroviral therapy, AIDS 2000;14:1675-1688.
Hasenclever D, Diehl V, Armitage JO et al. A prognostic score for advanced Hodgkin’se Disease, NEJM 1998 ; 339:1506-1514.
Valerie L, Michael S. McGraath, Pathogenesis of HIV- Associated Lymphoma, HIV inSite Knowledge Base Chapter Published November 2002.
Hoffmann C, Chow KU, Wolf E et all. Outcome of HIV-associated Hodgkin disease is improved by highly active antiretroviral therapy. 7th International Conference on Malignancies and AIDS and Other Immunodeficiencies, April 28-29 Natcher Conference Center, Bethesda- Maryland, abs
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
